DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Reviewed by the HealthVetted Editorial
Insulin resistance is a condition in which the body's cells respond poorly to the hormone insulin, so the pancreas has to make more and more of it to keep blood sugar normal. It is not a disease you can usually feel, but it sits at the root of prediabetes, type 2 diabetes, and much of the metabolic dysfunction that drives heart disease — and, importantly, it is often improvable through everyday changes.
Insulin is a hormone made by the pancreas. After you eat, it acts like a key that tells your cells — especially in muscle, fat, and the liver — to take glucose (sugar) out of the bloodstream and either use it for energy or store it. In insulin resistance, those cells stop responding normally to that key. Glucose lingers in the blood, so the pancreas compensates by pumping out extra insulin.
For a while, this compensation works: blood sugar stays in the normal range, but only because insulin levels are quietly running high (a state called hyperinsulinemia). This is why insulin resistance can exist for years before a routine glucose test ever looks abnormal. Over time, if the insulin-producing beta cells can no longer keep up with demand, blood glucose begins to rise — first into the prediabetes range, then potentially into type 2 diabetes (NIH; StatPearls).
Insulin resistance is best understood not as an on/off switch but as a spectrum of metabolic strain. It overlaps heavily with metabolic syndrome — a cluster of risk factors including abdominal obesity, high blood pressure, high triglycerides, low HDL ("good") cholesterol, and elevated fasting glucose — and is a central feature of conditions such as type 2 diabetes, prediabetes, polycystic ovary syndrome (PCOS), and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD).
Insulin resistance is a physiological state rather than a single billable diagnosis. Related conditions carry their own ICD-10 codes — for example, R73.03 for prediabetes and E88.81 for metabolic syndrome — while the broader concept of impaired glucose regulation is captured under R73.09.
Insulin resistance arises from a combination of genetics and, more powerfully, modifiable lifestyle and body-composition factors. The mechanism most researchers emphasize is the accumulation of excess fat where it does not belong — particularly visceral fat packed around the abdominal organs and fat deposited inside the liver and muscle. This ectopic fat releases free fatty acids and inflammatory signals that interfere with insulin's normal action inside cells (StatPearls; NIH).
Major contributing factors and risk groups include:
Some causes are not lifestyle-related at all. Pregnancy induces a normal, temporary rise in insulin resistance. Rarer causes include genetic syndromes, hormonal disorders such as Cushing's syndrome and acromegaly, and certain inherited lipodystrophies (StatPearls).
It is worth stressing that insulin resistance is not exclusive to people with obesity. So-called "lean" or metabolically unhealthy normal-weight individuals can have significant insulin resistance, typically reflecting where their fat is stored and their muscle and activity levels rather than the number on the scale.
For most people, the honest answer is that insulin resistance itself produces no clear symptoms. This is precisely what makes it dangerous — it can advance silently for years. It is usually inferred from blood tests, body measurements, and associated conditions rather than from how a person feels.
When physical signs do appear, they tend to reflect the metabolic strain or the high insulin levels rather than the resistance directly:
Because symptoms are unreliable, clinicians focus on screening high-risk individuals rather than waiting for complaints. The presence of acanthosis nigricans, a large waist circumference, PCOS, or a strong family history should prompt evaluation even in someone who feels well.
There is no single, universally used clinical test that a doctor orders specifically labeled "insulin resistance test." In routine practice, the condition is identified indirectly — through glucose-based testing, surrogate calculations, and assessment of associated risk factors. Research settings use a precise measure (the hyperinsulinemic-euglycemic clamp), but that is impractical for everyday care (StatPearls).
The practical workup typically includes:
Glucose-based tests (the formal basis for prediabetes/diabetes). Per the American Diabetes Association (ADA) Standards of Care in Diabetes (2026), prediabetes — a downstream marker that insulin resistance has begun to outpace compensation — is defined by any of the following (ADA):
Fasting insulin and HOMA-IR. Because insulin rises before glucose does, some clinicians measure fasting insulin and calculate the HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) from fasting glucose and insulin. Higher values suggest greater resistance. However, there is no single, internationally standardized cutoff, and results vary by laboratory, assay, and population — so HOMA-IR is best treated as a supportive clue rather than a definitive diagnosis, and it is not part of formal ADA diagnostic criteria.
Metabolic syndrome assessment. A widely used and practical proxy is to screen for metabolic syndrome. Under the 2009 harmonized definition (a joint statement involving the AHA, NHLBI, IDF and others), it is diagnosed when three or more of the following five are present (AHA/NHLBI harmonized criteria):
Supporting labs. Clinicians often also check a lipid panel, liver enzymes (to screen for associated fatty liver), and may consider triglyceride-to-HDL ratio as a rough surrogate of insulin resistance.
Treatment follows a clear hierarchy: lifestyle change is the foundation for everyone, and medication is added for higher-risk individuals or those progressing toward diabetes. The goal is to reduce the metabolic load on the system, lower insulin demand, and prevent or delay type 2 diabetes and cardiovascular disease.
Lifestyle modification is the most powerful and best-evidenced intervention. In the landmark Diabetes Prevention Program (DPP), an intensive lifestyle program reduced progression from prediabetes to type 2 diabetes substantially — and was more effective overall than the medication arm (ADA; NIH). The core elements:
These steps also improve the conditions that travel with insulin resistance — blood pressure, cholesterol, and fatty liver.
Evidence here is mixed and should be discussed with a clinician; supplements are not a substitute for lifestyle change or prescribed therapy. Some agents studied in this space include inositol (notably myo-inositol, with the most data in PCOS-related insulin resistance), magnesium (mainly when intake is low), berberine, chromium, and soluble fiber. Quality of evidence varies widely and product purity is unregulated. None is FDA-approved to treat insulin resistance, and some can interact with medications — so professional guidance is important before starting any.
There is no drug approved with the sole indication "insulin resistance." Instead, medications are prescribed for prediabetes risk reduction or for the associated conditions, and several improve insulin sensitivity as a benefit. Real drug classes and agents used include:
Drug choice is individualized based on weight, glucose level, other conditions, and cardiovascular risk, and should be made with a clinician.
In large part, yes — because its main drivers are modifiable. The same habits that reverse early insulin resistance also prevent it and keep prediabetes from progressing to diabetes:
Long-term management is a partnership with periodic re-checking (such as repeat HbA1c or fasting glucose) and steady attention to the cluster of cardiometabolic factors. The encouraging reality is that insulin sensitivity is dynamic — it can improve substantially, sometimes within weeks of consistent activity and dietary change, and early insulin resistance is frequently reversible before permanent beta-cell decline sets in.
Talk to a clinician for evaluation if you have risk factors — a large waist, a family history of type 2 diabetes, PCOS, a history of gestational diabetes, high blood pressure or abnormal cholesterol, or signs like acanthosis nigricans (darkened velvety skin patches) — even if you feel well, so your glucose and metabolic risk can be checked.
Seek prompt medical care if you develop symptoms that may signal that blood sugar has risen significantly, including:
Symptoms such as confusion, very rapid breathing, fruity-smelling breath, severe abdominal pain, or vomiting require emergency care, as they can indicate dangerously high blood sugar.
For most people the outlook is favorable, especially when insulin resistance is caught and addressed early. Because the condition is largely driven by modifiable factors, sustained lifestyle change can restore much of the body's insulin sensitivity and meaningfully lower the chance of ever developing type 2 diabetes.
The prognosis depends heavily on what happens next. Left unaddressed, insulin resistance tends to progress — from compensated high-insulin states, to prediabetes, to type 2 diabetes — and it raises the long-term risk of cardiovascular disease, fatty liver disease, and other complications. Acted on early, that trajectory can often be slowed, halted, or partially reversed.
The key message is one of agency: insulin resistance is among the most modifiable of the major metabolic risk states. Good care for it looks a great deal like good heart-health care, and the benefits extend well beyond blood sugar to blood pressure, cholesterol, weight, and overall longevity.
Can insulin resistance be reversed? Often, yes — particularly in its earlier stages. Sustained weight loss of around 5–7% of body weight, regular exercise (especially strength training plus aerobic activity), a fiber-rich diet low in added sugar, and better sleep can substantially improve insulin sensitivity, sometimes within weeks. The longer insulin resistance has progressed toward diabetes, the harder it is to fully reverse, which is why acting early matters.
Is insulin resistance the same as diabetes? No. Insulin resistance is an underlying state in which cells respond poorly to insulin; the pancreas compensates by making more. Diabetes occurs later, when the pancreas can no longer keep blood sugar in the normal range. Insulin resistance can exist for years with completely normal glucose tests, and it is a major driver of prediabetes and type 2 diabetes rather than the same condition.
What blood test shows insulin resistance? There is no single definitive test in routine care. Doctors usually rely on glucose-based tests (fasting glucose, HbA1c, or an oral glucose tolerance test) to detect prediabetes, sometimes alongside a fasting insulin level or a calculated HOMA-IR, plus a lipid panel and waist measurement. HOMA-IR has no universal cutoff and varies by lab, so it is treated as a supportive clue rather than a formal diagnosis.
What foods should I avoid with insulin resistance? The strongest evidence points to cutting back on sugar-sweetened beverages, sweets, refined and highly processed carbohydrates (like white bread, pastries, and sugary cereals), and ultra-processed foods. Emphasizing vegetables, legumes, whole grains, fiber, lean proteins, and healthy fats — broadly a Mediterranean-style pattern — is well supported. Total calories matter when weight loss is a goal; no single food cures insulin resistance.
Does insulin resistance cause weight gain, or does weight gain cause insulin resistance? The relationship runs in both directions and forms a cycle. Excess fat, especially around the abdomen and inside the liver, promotes insulin resistance; in turn, high insulin levels can make fat storage easier and weight loss harder. Breaking the cycle usually starts with activity and dietary change, which improve insulin sensitivity even before much weight is lost.
*This page is for general education and is not medical advice. Talk to a qualified healthcare professional about diagnosis and treatment decisions specific to you.*
No medication is FDA-approved specifically to treat "insulin resistance" as a standalone diagnosis. The strongest evidence-based intervention is structured lifestyle change—about 7% weight loss and at least 150 minutes of weekly physical activity—which reduced progression to type 2 diabetes by 58% in the NIH Diabetes Prevention Program. Metformin (FDA-approved for type 2 diabetes) is sometimes used off-label for prediabetes and reduced diabetes risk by 31% in the same trial; it should only be taken under a clinician's supervision. Other glucose-lowering or weight-management medications may be appropriate for some individuals and should be discussed with a healthcare provider. Be cautious with unregulated supplements marketed to "reverse insulin resistance," as these are not FDA-approved for this use and generally lack rigorous evidence.
In many people insulin resistance can be substantially improved or reversed, especially when it is driven by lifestyle factors like excess body fat and inactivity. Losing even a modest amount of weight, exercising regularly, and improving diet can make cells more responsive to insulin, and some people return their blood sugar to a healthy range. However, not every cause is reversible — insulin resistance linked to genetics, aging, or hormone disorders may persist, and improvements can fade if healthy habits stop. Work with a clinician to set realistic goals and a personalized plan.
Insulin resistance is most often driven by excess body fat (particularly visceral fat around the organs), physical inactivity, and a diet high in processed foods and refined carbohydrates. Genetics, increasing age, a family history of diabetes, poor sleep, smoking, and certain medications (such as steroids) also raise risk. Some hormone disorders — including PCOS, Cushing's syndrome, and hypothyroidism — can contribute as well. A clinician can help identify which factors apply to you.
Insulin resistance often causes no noticeable symptoms in its early stages, which is why it can go undetected for years. Possible physical signs include dark, velvety skin patches (called acanthosis nigricans) on the neck, armpits, or groin, skin tags, and an increasing waistline. As it progresses toward prediabetes or diabetes, symptoms like increased thirst, frequent urination, fatigue, and blurred vision may appear. Because it is often silent, blood testing is the only reliable way to confirm it.
There is no single standard blood test that directly diagnoses insulin resistance, so clinicians infer it from related results and risk factors. Common tests include fasting blood glucose, A1C, and a lipid panel; prediabetes (a strong marker of resistance) is generally defined as a fasting glucose of 100–125 mg/dL, an A1C of 5.7–6.4%, or a 2-hour oral glucose tolerance result of 140–199 mg/dL. Some clinicians also use a HOMA-IR score, calculated from fasting insulin and glucose, though thresholds vary by population and it is not universally standardized. A healthcare provider should interpret results in the context of your overall health.
Insulin resistance is the underlying problem in which cells respond poorly to insulin, forcing the pancreas to make more to keep blood sugar normal. Prediabetes occurs when blood sugar starts to rise above normal but is not yet in the diabetic range (for example, A1C 5.7–6.4% or fasting glucose 100–125 mg/dL). Type 2 diabetes is diagnosed when blood sugar crosses higher thresholds, such as an A1C of 6.5% or higher or a fasting glucose of 126 mg/dL or above. They sit on a continuum, and catching insulin resistance early offers the best chance to prevent progression.
Lifestyle changes are the first-line and most effective treatment for insulin resistance: regular physical activity, weight loss if appropriate, and a diet emphasizing whole foods while limiting refined carbohydrates and sugary drinks. No medication is specifically approved to cure insulin resistance, but doctors may prescribe metformin for people with prediabetes or diabetes, and may treat related conditions such as high blood pressure or cholesterol. Treatment should be individualized, so consult a clinician before starting any medication or major dietary change.
Yes — it is common to have insulin resistance while fasting glucose and A1C still appear normal. In the early stages, the pancreas compensates by releasing extra insulin, which keeps blood sugar in the normal range and can mask the underlying problem for years. This is one reason insulin resistance is often missed until it progresses to prediabetes. If you have risk factors like excess weight, a family history of diabetes, or signs such as acanthosis nigricans, discuss additional testing with your clinician.
There is no fixed timeline, as it depends on the severity, the underlying causes, and how consistently lifestyle changes are followed. Some people see measurable improvements in insulin sensitivity within a few weeks to a few months of regular exercise, dietary changes, and weight loss, while others take longer or need ongoing management. Sustained habits matter more than speed, because benefits can reverse if healthy routines stop. A healthcare provider can track your progress with periodic blood tests.
Independent, evidence-based reviews — not paid placements. See our full analysis:
This page is for general information and is not medical advice. Always consult a qualified clinician about diagnosis and treatment. Individual results vary.